日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer

雌激素受体靶向治疗诱导 TEAD 辅激活因子 VGLL1 导致乳腺癌产生耐药性

Carolina Gemma, Chun-Fui Lai, Anup K Singh, Antonino Belfiore, Neil Portman, Heloisa Z Milioli, Manikandan Periyasamy, Sara Raafat, Alyssa J Nicholls, Claire M Davies, Naina R Patel, Georgia M Simmons, Hailing Fan, Van T M Nguyen, Luca Magnani, Emad Rakha, Lesley-Ann Martin, Elgene Lim, R Charles Co

Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

更正:CDK7抑制剂CT7001(Samuraciclib)靶向增殖通路以抑制晚期前列腺癌。

Constantin, Theodora A; Varela-Carver, Anabel; Greenland, Kyle K; de Almeida, Gilberto Serrano; Olden, Ellen; Penfold, Lucy; Ang, Simon; Ormrod, Alice; Leach, Damien A; Lai, Chun-Fui; Ainscow, Edward K; Bahl, Ash K; Carling, David; Fuchter, Matthew J; Ali, Simak; Bevan, Charlotte L

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

蛋白质组学分析显示 ESR1 突变增强细胞周期蛋白依赖性激酶信号传导

Tommaso De Marchi, Chun-Fui Lai, Georgia M Simmons, Isabella Goldsbrough, Alison Harrod, Thai Lam, Lakjaya Buluwela, Sven Kjellström, Christian Brueffer, Lao H Saal, Johan Malmström, Simak Ali, Emma Niméus

The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

CDK7 抑制剂 CT7001 (Samuraciclib) 靶向增殖途径以抑制晚期前列腺癌

Theodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, Gilberto Serrano de Almeida, Ellen Olden, Lucy Penfold, Simon Ang, Alice Ormrod, Damien A Leach, Chun-Fui Lai, Edward K Ainscow, Ash K Bahl, David Carling, Matthew J Fuchter, Simak Ali, Charlotte L Bevan

Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer

雌激素受体突变的基因组工程揭示了对抗雌激素的不同反应和乳腺癌的新预后基因特征

Alison Harrod, Chun-Fui Lai, Isabella Goldsbrough, Georgia M Simmons, Natasha Oppermans, Daniela B Santos, Balazs Győrffy, Rebecca C Allsopp, Bradley J Toghill, Kirsty Balachandran, Mandy Lawson, Christopher J Morrow, Manasa Surakala, Larissa S Carnevalli, Pei Zhang, David S Guttery, Jacqueline A Sh

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance

撤稿声明:FOXM1 通过胸苷酸合成酶 (TYMS) 调节胆管癌细胞对 5-氟尿嘧啶的敏感性:FOXM1-TYMS 轴解偶联在 5-FU 耐药中的意义

Intuyod, Kitti; Saavedra-García, Paula; Zona, Stefania; Lai, Chun-Fui; Jiramongkol, Yannasittha; Vaeteewoottacharn, Kulthida; Pairojkul, Chawalit; Yao, Shang; Yong, Jay-Sze; Trakansuebkul, Sasanan; Waraasawapati, Sakda; Luvira, Vor; Wongkham, Sopit; Pinlaor, Somchai; Lam, Eric W-F

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance

FOXM1 通过胸苷酸合酶 (TYMS) 调节胆管癌中的 5-氟尿嘧啶敏感性:FOXM1-TYMS 轴解偶联对 5-FU 耐药性的影响

Kitti Intuyod, Paula Saavedra-García, Stefania Zona, Chun-Fui Lai, Yannasittha Jiramongkol, Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Shang Yao, Jay-Sze Yong, Sasanan Trakansuebkul, Sakda Waraasawapati, Vor Luvira, Sopit Wongkham, Somchai Pinlaor, Eric W-F Lam

LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner

LRH-1 以 p53 依赖的方式抑制 CDKN1A 基因表达,从而促进结肠癌细胞生长

Holly B Kramer, Chun-Fui Lai, Hetal Patel, Manikandan Periyasamy, Meng-Lay Lin, Stephan M Feller, Frances V Fuller-Pace, David W Meek, Simak Ali, Laki Buluwela

Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer

CDK7、细胞周期蛋白 H 和 MAT1 在乳腺癌中的表达升高,并且对雌激素受体阳性乳腺癌具有预后作用

Hetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, Manikandan Periyasamy, Alison Harrod, Carolina Gemma, Jennifer H Steel, Naina Patel, Claudia Busonero, Dena Jerjees, Judit Remenyi, Sally Smith, Jennifer J Gomm, Luca Magnani, Balázs Győrffy, Louise J Jones, Frances Fuller-Pace, Sami Shousha, Laki Buluw